Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing v3.6.3, signaling that a newer version of the study document is referenced on the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a new revision tag (v3.6.3) replacing v3.6.2, indicating a minor software update. No study details or content appear affected by this change.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision was updated from `v3.6.0` to `v3.6.2`, indicating a backend update; no substantive study details appear to be affected.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows that recruitment is closed with the message 'No longer looking for participants'. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the page revision was updated to v3.6.0, reflecting navigation refinements and a new version release.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation or formatting.SummaryDifference0.1%

- Check80 days agoChange Detected- The page revision was updated from v3.5.3 to v3.5.4, reflecting a minor metadata update to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.